Patent 7612180 was granted and assigned to IMMUNOMEDICS, INC. on November, 2009 by the United States Patent and Trademark Office.
Humanized antibodies are provided that specifically bind HLA-DR. The antibodies recognize the epitope recognized by the murine monoclonal antibody L243. Processes for preparing such antibodies, pharmaceutical compositions containing such antibodies, and clinical therapuetic and diagnostic, as well as research-related uses for such antibodies, are provided.